quinazolines has been researched along with balaglitazone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamali, B; Sørensen, LL; Theill, GC | 1 |
| Fleckner, J; Larsen, LK; Larsen, PJ; Lykkegaard, K; Sauerberg, P; Wassermann, K; Wulff, EM | 1 |
| Beck-Nielsen, H; Byrjalsen, I; Christiansen, C; Henriksen, K; Karsdal, MA; Larsen, LK; Madsen, AN; Nielsen, RH | 1 |
| Beck-Nielsen, H; Byrjalsen, I; Christiansen, C; Gram, J; Hansen, G; Henriksen, K; Karsdal, MA; Perrild, H; Qvist, P; Riis, BJ; Svendsen, OL | 1 |
| Agrawal, R; Dikshit, SN; Jain, P | 1 |
| Byrjalsen, I; Christiansen, C; Genovese, F; Henriksen, K; Karsdal, MA; Leeming, DJ; Nielsen, MJ; Riis, BJ; Schuppan, D | 1 |
| Byrjalsen, I; Christiansen, C; Gardner, S; Goodman, Z; Henriksen, K; Karsdal, MA; Krag, A; Leeming, DJ; Nielsen, MJ; Patel, K; Schuppan, D | 1 |
| Azimi, A; Badalzadeh, R; Baradaran, B; Majidinia, M; Samadi, N; Shafiei-Irannejad, V; Yousefi, B; Zarghami, N | 1 |
1 review(s) available for quinazolines and balaglitazone
| Article | Year |
|---|---|
Balaglitazone: a second generation peroxisome proliferator-activated receptor (PPAR) gamma (γ) agonist.
Topics: Animals; Humans; Hypoglycemic Agents; Ligands; PPAR gamma; Quinazolines; Structure-Activity Relationship; Thiazolidinediones | 2012 |
3 trial(s) available for quinazolines and balaglitazone
| Article | Year |
|---|---|
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy.
Topics: Aged; Blood Glucose; Body Composition; Bone Density; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pioglitazone; PPAR gamma; Quinazolines; Thiazolidinediones; Water-Electrolyte Balance; Weight Gain | 2011 |
Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.
Topics: Adipose Tissue; Aged; Blood Glucose; Collagen Type VI; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptide Fragments; Pioglitazone; PPAR gamma; Quinazolines; Thiazolidinediones | 2017 |
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.
Topics: Biomarkers; Collagen Type III; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Oxazoles; Patient Selection; Quinazolines; Thiazolidinediones; Tyrosine | 2016 |
4 other study(ies) available for quinazolines and balaglitazone
| Article | Year |
|---|---|
Generic, highly selective and robust capillary electrophoresis method for separation of a racemic mixture of glitazone compounds.
Topics: Cyclodextrins; Electrolytes; Electrophoresis, Capillary; Hypoglycemic Agents; Indicators and Reagents; Pioglitazone; Quinazolines; Reproducibility of Results; Rosiglitazone; Solutions; Stereoisomerism; Tablets; Thiazolidinediones | 2004 |
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Topics: Adipogenesis; Adipose Tissue; Animals; Blood Volume; Body Weight; Drinking; Eating; Heart; Humans; Hypoglycemic Agents; Male; Mice; Organ Size; PPAR gamma; Quinazolines; Rats; Rosiglitazone; Thiazolidinediones | 2008 |
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Topics: Adipogenesis; Animals; Biomarkers; Blood Glucose; Body Weight; Bone and Bones; Bone Resorption; Diet; Glucose Tolerance Test; Hypoglycemic Agents; Lipid Metabolism; Magnetic Resonance Imaging; Male; Muscles; Obesity; Osteogenesis; Pioglitazone; PPAR alpha; Quinazolines; Rats; Thiazolidinediones; Water | 2009 |
Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Polymerase Chain Reaction; PPAR gamma; PTEN Phosphohydrolase; Quinazolines; Signal Transduction; Thiazolidinediones; Up-Regulation | 2017 |